While the activation of NFE2L2 has been evaluated in cancer prevention in clinical trials, it has been claimed that the constitutive activation of NFE2L2 contributes to the survival and growth of cancer cells in many types of tumours [115]. The gene discussed is NFE2L2; the disease is cancer.